Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Operating Expenses | 6,814 | 4,683 | 5,899 | 4,657 | 4,840 |
| Operating Income | -6,814 | -4,683 | -5,899 | -4,657 | -4,840 |
| Other Income | 14 | 12 | 12 | 14 | 14 |
| Pre-tax Income | -6,800 | -4,671 | -5,887 | -4,643 | -4,826 |
| Net Income Continuous | -6,800 | -4,671 | -5,887 | -4,643 | -4,826 |
| Net Income | $-6,800 | $-4,671 | $-5,887 | $-4,643 | $-4,826 |
| EPS Basic Total Ops | -0.24 | -0.19 | -0.26 | -0.21 | -0.22 |
| EPS Basic Continuous Ops | -0.24 | -0.18 | -0.25 | -0.20 | -0.21 |
| EPS Diluted Total Ops | -0.24 | -0.19 | -0.26 | -0.21 | -0.22 |
| EPS Diluted Continuous Ops | -0.24 | -0.18 | -0.25 | -0.20 | -0.21 |
| EBITDA(a) | $-6,813 | $-4,682 | $-5,897 | $-4,655 | $-4,838 |